Hiab to supply Notterkran with 110 MULTILIFT hooklifts for the Swiss Army
CARGOTEC CORPORATION, PRESS RELEASE 4 FEBRUARY 2021 AT 1:45 PM EET
Hiab, part of Cargotec, has signed an agreement to supply the Swiss Hiab dealer Notterkran 110 MULTILIFT hooklifts for application by the Swiss Army. The order was booked in the fourth quarter of 2020.
This order is for a new generation vehicle family of the Swiss Army, whereby the Swiss Army is planning to procure more hooklift vehicles in the near future.
The MULTILIFT ULT21Z.59+SC hooklifts with Container Handling Unit, which handle flatracks and 20ft ISO containers, will be installed on the vehicles by Notterkran and supplied to armasuisse, The Swiss Federal Office for Defence Procurement.
KHL Group
Log In We have recently updated our website and if this your first time logging in this year you will need to set a new password. Please click here to begin.
Using e-mail
Log In We have recently updated our website and if this your first time logging in this year you will need to set a new password. Please click here to begin.
Using e-mail
By Christian Shelton04 February 2021
Load handling equipment specialist Hiab has signed an agreement to supply Munich, Germany-headquartered Rheinmetall MAN Military Vehicles (RMMV) with up to 4,000 Multilift hooklifts by 2027. This would have a value of more than €180 million (US$218 million), said Hiab. The initial order, booked in 2020, is for 540 units. Hiab has also signed an agreement with its Swiss Hiab dealer Notterkran to supply 110 Multilift hooklifts for use by the Swiss Army.
Novartis agrees to help Pfizer-BioNTech produce Covid-19 vaccine
Novartis is based in Basel Keystone / Georgios Kefalas
Swiss pharma giant Novartis says it has signed an initial agreement to provide manufacturing capacity for Pfizer and BioNTech s Covid-19 vaccine.
This content was published on January 29, 2021 - 13:14
January 29, 2021 - 13:14
Reuters/Novartis/SWI swissinfo.ch/ilj
See in other languages: 3
The move aimed at helping boost production as demand currently outstrips supply. The agreement will see Novartis utilizing its aseptic manufacturing facilities at its site in Stein, Switzerland, Novartis said in a statement on Friday. External link Subject to reaching a final agreement, Novartis plans to commence production in the second quarter of 2021.
Swiss exempt from EU vaccine export controls
European Commissioner Valdis Dombrovskis speaks during an online news conference on Friday Copyright 2020 The Associated Press. All Rights Reserved
Switzerland is among the countries exempt from the European Union’s vaccine export controls, the European Commission said on Friday. The plan has been drawn up to ensure that the EU has enough supplies of Covid-19 vaccine.
This content was published on January 29, 2021 - 18:22
January 29, 2021 - 18:22
Reuters/Keystone-SDA/SWI swissinfo.ch/ilj
EU trade commissioner Valdis Dombrovskis told a news conference that the export monitoring and controls were time limited , initially lasting until the end of March, and applied to Covid-19 vaccines the EU had bought in advance.